Summary & Overview
HCPCS C7560: ERCP with Stent or Foreign Body Removal and Duct Visualization
HCPCS Level II code C7560 represents an advanced endoscopic procedure: endoscopic retrograde cholangiopancreatography (ERCP) with removal of foreign body(s) or stent(s) from the biliary or pancreatic ducts, combined with endoscopic cannulation of the papilla and direct visualization of the pancreatic and common bile ducts. This code captures a therapeutic ERCP encounter where device removal and ductal inspection are central and often determines downstream care.
This analysis covers major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, typical sites of service, and the payer landscape relevant to coverage and claims classification. The publication outlines expected billing considerations, common modifiers used with similar procedures (input provided), and where documentation typically aligns with the coded service.
Readers will learn how C7560 is used to represent combined removal and diagnostic visualization during ERCP, what clinical workflows commonly accompany the service (endoscopy suite in hospital outpatient or ambulatory surgical center), and which payers are commonly engaged for authorization and payment. Data not available in the input will be identified explicitly in specific sections of the full publication.
Billing Code Overview
HCPCS Level II code C7560 describes endoscopic retrograde cholangiopancreatography (ERCP) with removal of foreign body(s) or stent(s) from biliary/pancreatic duct(s) and endoscopic cannulation of papilla with direct visualization of pancreatic/common bile duct(s).
Service type: Therapeutic endoscopic biliary/pancreatic procedure involving device removal and duct visualization.
Typical site of service: Hospital outpatient department or ambulatory surgical center (endoscopy suite).
Clinical & Coding Specifications
Clinical Context
A 62-year-old male with a history of choledocholithiasis presents with acute right upper quadrant pain, jaundice, and elevated liver function tests. Imaging with transabdominal ultrasound and MRCP demonstrates dilation of the common bile duct and a retained biliary plastic stent from a prior procedure, as well as suspected filling defect consistent with a stone. The gastroenterology team schedules an endoscopic retrograde cholangiopancreatography procedure with planned endoscopic cannulation of the papilla, direct cholangiopancreatoscopic visualization of the biliary and/or pancreatic ducts, and removal of the retained stent and/or foreign body.
The clinical workflow includes pre-procedure evaluation (history, medication reconciliation, informed consent, coagulation assessment), procedural sedation or monitored anesthesia care, endoscopic cannulation of the ampulla of Vater, direct visualization of the biliary and/or pancreatic ducts using endoscopic imaging, extraction of the foreign body or stent using retrieval devices (eg, baskets, graspers), ductal clearance assessment, and post-procedure recovery with instructions and documentation of findings and devices removed. Typical intra-procedural documentation includes indication, technique (selective cannulation, cholangiopancreatoscopy), devices used, foreign body/stent characteristics, specimen or device disposition, complications, and planned follow-up.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |